The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Nanoceria: A Rare-Earth Nanoparticle as a Novel Anti-Angiogenic Therapeutic Agent in Ovarian Cancer
Open accessAbstract
Ovarian cancer (OvCa) is the fifth most common cause of death from all cancers among women in United Sates and the leading cause of death from gynecological malignancies. While most OvCa patients initially respond to surgical debulking and chemotherapy, 75% of patients later succumb to the disease. Thus, there is an urgent need to test novel therapeutic agents to counteract the high mortality rate associated with OvCa. In this context, we have developed and engineered Nanoceria (NCe), nanoparticles of cerium oxide, possessing anti-oxidant properties, to be used as a therapeutic agent in OvCa. We show for the first time that NCe significantly inhibited production of reactive oxygen species (ROS) in A2780 cells, attenuated growth factor (SDF1, HB-EGF, VEGF(165) and HGF) mediated cell migration and invasion of SKOV3 cells, without affecting the cell proliferation. NCe treatment also inhibited VEGF(165) induced proliferation, capillary tube formation, activation of VEGFR2 and MMP2 in human umbilical vascular endothelial cells (HUVEC). NCe (0.1 mg/kg body weigh) treatment of A2780 ovarian cancer cells injected intra-peritoneally in nude mice showed significant reduction (p<0.002) in tumor growth accompanied by decreased tumor cell proliferation as evident from reduced tumor size and Ki67 staining. Accumulation of NCe was found in tumors isolated from treated group using transmission electron microscopy (TEM) and inductively coupled plasma mass spectroscopy (ICP-MS). Reduction of the tumor mass was accompanied by attenuation of angiogenesis, as observed by reduced CD31 staining and specific apoptosis of vascular endothelial cells. Collectively, these results indicate that cerium oxide based NCe is a novel nanoparticle that can potentially be used as an anti-angiogenic therapeutic agent in ovarian cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tumor angiogenesis: therapeutic implications
Sherwood, L. M., Parris, E. E., & Folkman, J. (1971) · New England Journal of Medicine · doi:10.1056/nejm197111182852108 · Cited by 10,187
Angiogenesis in cancer and other diseases
Carmeliet, P., & Jain, R. K. (2000) · Nature · doi:10.1038/35025220 · Cited by 9,070 · cited 1×
“This abnormal angiogenesis is required for the growth, survival, and metastasis of most solid tumors [7,8].”
BackgroundTumor Angiogenesis and Metastasis — Correlation in Invasive Breast Carcinoma
Weidner, N., Semple, J. P., Welch, W. R., & Folkman, J. (1991) · New England Journal of Medicine · doi:10.1056/nejm199101033240101 · Cited by 5,627
Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma.
Weidner, N., Carroll, P. R., Flax, J. D., Blumenfeld, W., & Folkman, J. (1993) · PubMed Central · Cited by 1,620
Clinical translation of angiogenesis inhibitors
Kerbel, R., & Folkman, J. (2002) · Nature Reviews Cancer · doi:10.1038/nrc905 · Cited by 1,517
Size dependency variation in lattice parameter and valency states in nanocrystalline cerium oxide
Deshpande, S., Patil, S., Kuchibhatla, S. V., & Seal, S. (2005) · Applied Physics Letters · doi:10.1063/1.2061873 · Cited by 1,135
Self-citationProtein adsorption and cellular uptake of cerium oxide nanoparticles as a function of zeta potential
Patil, S., Sandberg, A., Heckert, E., Self, W., & Seal, S. (2007) · Biomaterials · doi:10.1016/j.biomaterials.2007.07.029 · Cited by 1,044
Self-citationBurger, R. A., Sill, M. W., Monk, B. J., Greer, B. E., & Sorosky, J. I. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.11.5345 · Cited by 882
Rare earth nanoparticles prevent retinal degeneration induced by intracellular peroxides
Chen, J., Patil, S., Seal, S., & McGinnis, J. F. (2006) · Nature Nanotechnology · doi:10.1038/nnano.2006.91 · Cited by 880
Self-citationVacancy Engineered Ceria Nanostructures for Protection from Radiation-Induced Cellular Damage
Tarnuzzer, R. W., Colon, J., Patil, S., & Seal, S. (2005) · Nano Letters · doi:10.1021/nl052024f · Cited by 816
Self-citation
Cited by
Nanomaterials with enzyme-like characteristics (nanozymes): next-generation artificial enzymes (II)
Wu, J., Wang, X., Wang, Q., Lou, Z., Li, S., Zhu, Y., Qin, L., & Wei, H. (2019) · Chemical Society Reviews · doi:10.1039/c8cs00457a · Cited by 4,108
Nanomaterials with enzyme-like characteristics (nanozymes): next-generation artificial enzymes
Wei, H., & Wang, E. (2013) · Chemical Society Reviews · doi:10.1039/c3cs35486e · Cited by 3,779
Butyrate: A Double-Edged Sword for Health?
Liu, H., Wang, J., He, T., Becker, S., Zhang, G., Li, D., & Ma, X. (2018) · Advances in Nutrition · doi:10.1093/advances/nmx009 · Cited by 1,144
Lanthanide Nanoparticles: From Design toward Bioimaging and Therapy
Dong, H., Du, S.-R., Zheng, X.-Y., Lyu, G.-M., Sun, L.-D., Li, L.-D., Zhang, P.-Z., Zhang, C., & Yan, C.-H. (2015) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00091 · Cited by 1,126
Recent Advances in Nanozyme Research
Wang, H., Wan, K., & Shi, X. (2019) · Advanced Materials · doi:10.1002/adma.201805368 · Cited by 974
Manne, N. D. P. K., Arvapalli, R., Graffeo, V. A., Bandarupalli, V. V. K., Shokuhfar, T., Patel, S., Rice, K. M., Ginjupalli, G. K., & Blough, E. R. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000479540 · Cited by 702
Cerium Oxide Nanoparticles: Applications and Prospects in Nanomedicine
Das, S., Dowding, J. M., Klump, K. E., McGinnis, J. F., Self, W., & Seal, S. (2013) · Nanomedicine · doi:10.2217/nnm.13.133 · Cited by 561
Self-citationAntioxidant Cerium Oxide Nanoparticles in Biology and Medicine
Nelson, B., Johnson, M., Walker, M., Riley, K., & Sims, C. (2016) · Antioxidants · doi:10.3390/antiox5020015 · Cited by 491
Antigen presentation by dendritic cells and their instruction of CD4+ T helper cell responses
Hilligan, K. L., & Ronchese, F. (2020) · Cellular & Molecular Immunology · doi:10.1038/s41423-020-0465-0 · Cited by 430
Cerium oxide nanoparticles: properties, biosynthesis and biomedical application
Singh, K. R., Nayak, V., Sarkar, T., & Singh, R. P. (2020) · RSC Advances · doi:10.1039/d0ra04736h · Cited by 428
Catalytic properties and biomedical applications of cerium oxide nanoparticles
Walkey, C., Das, S., Seal, S., Erlichman, J., Heckman, K., Ghibelli, L., Traversa, E., McGinnis, J. F., & Self, W. T. (2015) · Environmental Science: Nano · doi:10.1039/c4en00138a · Cited by 410
Self-citationRecent advances in metal nanoparticles in cancer therapy
Sharma, A., Goyal, A. K., & Rath, G. (2018) · Journal of Drug Targeting · doi:10.1080/1061186x.2017.1400553 · Cited by 341
Synthesis and biomedical applications of nanoceria, a redox active nanoparticle
Thakur, N., Manna, P., & Das, J. (2019) · Journal of Nanobiotechnology · doi:10.1186/s12951-019-0516-9 · Cited by 338
Morry, J., Ngamcherdtrakul, W., & Yantasee, W. (2017) · Redox Biology · doi:10.1016/j.redox.2016.12.011 · Cited by 333
Scavenging of reactive oxygen and nitrogen species with nanomaterials
Ferreira, C. A., Ni, D., Rosenkrans, Z. T., & Cai, W. (2018) · Nano Research · doi:10.1007/s12274-018-2092-y · Cited by 301
Nanotechnology for angiogenesis: opportunities and challenges
Kargozar, S., Baino, F., Hamzehlou, S., Hamblin, M. R., & Mozafari, M. (2020) · Chemical Society Reviews · doi:10.1039/c8cs01021h · Cited by 262
Current Challenges of Cancer Anti-angiogenic Therapy and the Promise of Nanotherapeutics
Abdalla, A. M. E., Xiao, L., Ullah, M. W., Yu, M., Ouyang, C., & Yang, G. (2018) · Theranostics · doi:10.7150/thno.21674 · Cited by 240
Combination of nanotechnology with vascular targeting agents for effective cancer therapy
Jahanban‐Esfahlan, R., Seidi, K., Banimohamad‐Shotorbani, B., Jahanban‐Esfahlan, A., & Yousefi, B. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.26051 · Cited by 84
Graham, U. M., Tseng, M. T., Jasinski, J. B., Yokel, R. A., Unrine, J. M., Davis, B. H., Dozier, A. K., Hardas, S. S., Sultana, R., Grulke, E. A., et al. (2014) · ChemPlusChem · doi:10.1002/cplu.201402080 · Cited by 72
Metadata
- Authors
- Giri, S., Karakoti, A., Graham, R. P., Maguire, J. L., Reilly, C. M., Seal, S., Rattan, R., & Shridhar, V.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2013-01-31
- Volume
- 8
- Issue
- 1
- Pages
- e54578
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2034564620
- Cited by
- 273
- References
- 49
- FWCI
- 9.82
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.